OssDsign Catalyst® was associated with new bone formation at 6 weeks in an ovine intramuscular model, showing trabecular-like bridging between granules and histologic features consistent with early bone development.
Public source
Publisher name
Public post
𝗪𝗵𝘆 𝗱𝗼 𝘀𝗼𝗺𝗲 𝘀𝘆𝗻𝘁𝗵𝗲𝘁𝗶𝗰 𝗴𝗿𝗮𝗳𝘁𝘀 𝗱𝗲𝗺𝗼𝗻𝘀𝘁𝗿𝗮𝘁𝗲 𝗯𝗼𝗻𝗲 𝗳𝗼𝗿𝗺𝗮𝘁𝗶𝗼𝗻 𝗶𝗻 𝗮𝘃𝗮𝘀𝗰𝘂𝗹𝗮𝗿 𝗲𝗻𝘃𝗶𝗿𝗼𝗻𝗺𝗲𝗻𝘁𝘀? Preclinical dat…
Company
OssDsign
OssDsign is a developer and global provider of next-generation bone graft-substitute products.
- Location
- Uppsala, SE
- Company size
- 11–50 employees
About OssDsign
OssDsign is a developer and global provider of next generation orthobiologics products. Based on cutting edge material science, the company develops and markets products that support the body's own healing capabilities, giving patients back the life they deserve. Website: www.ossdsign.com Newsroom: https://news.cision.com/ossdsign-ab (Always consult Instructions for Use which accompany the products for complete indications, contraindications, warnings and precautions.)
See moreLatest activity
Latest activity from OssDsign
4 signals
Presence & Recognition
OssDsign featured Dr. Andrew Thanh sharing real-world experience using the OssDsign Catalysts in spinal fusion procedures at the Catalyst conference on Friday, September 11th at Booth 215.
Presence & Recognition
OssDsign is recognizing surgeons, nurses, techs, and anesthesia teams in the OR during Labor Day.
Presence & Recognition
OssDsign will participate in the Society for Minimally Invasive Spine Surgery (SMISS) Annual Meeting in Las Vegas.
Discover more
Similar signals
Similar public activity from other companies.
Research & Knowledge
Biocomposites
Biocomposites reported a retrospective review of 17 patients with open fracture defects and non-unions treated with NanoBone® where all patients achieved union with an average time to union of 7.5 weeks.
Products & Services
Ethoss Regeneration Ltd
Ethoss Regeneration Ltd published a practical guide to preparing EthOss for placement, covering site preparation, mixing, graft placement, compression, and soft tissue closure.
Research & Knowledge
GreenBone Ortho
GreenBone Ortho published a study in Biomaterials Science describing interconnected multiscale porosity, damage-tolerant mechanical behaviour, osteogenic gene expression in vitro, and osteoinductive bone formation in vivo.
Research & Knowledge
OSSTEC
OSSTEC published 12-week preclinical results showing equivalent fixation for titanium and cobalt chromium alloy implants with cementless technology.
Research & Knowledge
Megagen Implants UK